118 related articles for article (PubMed ID: 36921737)
1. Human C1q Tumor Necrosis Factor 8 (CTRP8) defines a novel tryptase+ mast cell subpopulation in the prostate cancer microenvironment.
Krishnan SN; Thanasupawat T; Arreza L; Wong GW; Sfanos K; Trock B; Arock M; Shah GG; Glogowska A; Ghavami S; Hombach-Klonisch S; Klonisch T
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166681. PubMed ID: 36921737
[TBL] [Abstract][Full Text] [Related]
2. C1q/TNF-Related Proteins 1, 6 and 8 Are Involved in Corneal Epithelial Wound Closure by Targeting Relaxin Receptor RXFP1 In Vitro.
Nicolaus HF; Klonisch T; Paulsen F; Garreis F
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047812
[TBL] [Abstract][Full Text] [Related]
3. C1q-tumour necrosis factor-related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells.
Glogowska A; Kunanuvat U; Stetefeld J; Patel TR; Thanasupawat T; Krcek J; Weber E; Wong GW; Del Bigio MR; Hoang-Vu C; Hombach-Klonisch S; Klonisch T
J Pathol; 2013 Dec; 231(4):466-79. PubMed ID: 24014093
[TBL] [Abstract][Full Text] [Related]
4. Novel CTRP8-RXFP1-JAK3-STAT3 axis promotes Cdc42-dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells.
Glogowska A; Thanasupawat T; Beiko J; Pitz M; Hombach-Klonisch S; Klonisch T
Mol Oncol; 2022 Jan; 16(2):368-387. PubMed ID: 33960104
[TBL] [Abstract][Full Text] [Related]
5. RXFP1 is Targeted by Complement C1q Tumor Necrosis Factor-Related Factor 8 in Brain Cancer.
Thanasupawat T; Glogowska A; Burg M; Wong GW; Hoang-Vu C; Hombach-Klonisch S; Klonisch T
Front Endocrinol (Lausanne); 2015; 6():127. PubMed ID: 26322020
[TBL] [Abstract][Full Text] [Related]
6. C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance in human glioblastoma.
Thanasupawat T; Glogowska A; Burg M; Krcek J; Beiko J; Pitz M; Zhang GJ; Hombach-Klonisch S; Klonisch T
Mol Oncol; 2018 Sep; 12(9):1464-1479. PubMed ID: 29949238
[TBL] [Abstract][Full Text] [Related]
7. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
[TBL] [Abstract][Full Text] [Related]
8. Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis.
Feng S; Agoulnik IU; Truong A; Li Z; Creighton CJ; Kaftanovskaya EM; Pereira R; Han HD; Lopez-Berestein G; Klonisch T; Ittmann MM; Sood AK; Agoulnik AI
Endocr Relat Cancer; 2010 Dec; 17(4):1021-33. PubMed ID: 20861284
[TBL] [Abstract][Full Text] [Related]
9. Emerging roles for the relaxin/RXFP1 system in cancer therapy.
Thanasupawat T; Glogowska A; Nivedita-Krishnan S; Wilson B; Klonisch T; Hombach-Klonisch S
Mol Cell Endocrinol; 2019 May; 487():85-93. PubMed ID: 30763603
[TBL] [Abstract][Full Text] [Related]
10. Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomes.
Hempel Sullivan H; Maynard JP; Heaphy CM; Lu J; De Marzo AM; Lotan TL; Joshu CE; Sfanos KS
J Pathol; 2021 Apr; 253(4):415-426. PubMed ID: 33338262
[TBL] [Abstract][Full Text] [Related]
11. Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro.
Pereira BA; Lister NL; Hashimoto K; Teng L; Flandes-Iparraguirre M; Eder A; Sanchez-Herrero A; Niranjan B;
Biomaterials; 2019 Mar; 197():72-85. PubMed ID: 30641266
[TBL] [Abstract][Full Text] [Related]
12. Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix.
Cabanillas-Saez A; Schalper JA; Nicovani SM; Rudolph MI
Int J Gynecol Cancer; 2002; 12(1):92-8. PubMed ID: 11860542
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells.
Irani AM; Nilsson G; Miettinen U; Craig SS; Ashman LK; Ishizaka T; Zsebo KM; Schwartz LB
Blood; 1992 Dec; 80(12):3009-21. PubMed ID: 1281684
[TBL] [Abstract][Full Text] [Related]
14. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand.
Li L; Meng XW; Krilis SA
J Immunol; 1996 Jun; 156(12):4839-44. PubMed ID: 8648132
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum tryptase as a diagnostic oncological marker in canine versus human mast cell neoplasms.
De Vos S; Demeyere K; De Cock H; Devriendt N; Schwarzkopf I; Fortrie R; Roggeman T; Meyer E; De Spiegelaere W; de Rooster H
Res Vet Sci; 2022 Dec; 151():90-95. PubMed ID: 35872552
[TBL] [Abstract][Full Text] [Related]
16. Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290.
Huang Z; Myhr C; Bathgate RA; Ho BA; Bueno A; Hu X; Xiao J; Southall N; Barnaeva E; Agoulnik IU; Marugan JJ; Ferrer M; Agoulnik AI
Front Endocrinol (Lausanne); 2015; 6():128. PubMed ID: 26347712
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.
Xu W; Qian J; Zeng F; Li S; Guo W; Chen L; Li G; Zhang Z; Wang QJ; Deng F
J Exp Clin Cancer Res; 2019 Mar; 38(1):114. PubMed ID: 30841931
[TBL] [Abstract][Full Text] [Related]
18. Application of novel tissue microarrays to investigate expression of tryptase, chymase and KIT protein in placental mast cells.
Noack F; Krüger S; Thorns C; Finas D; Stöcker W; Diedrich K; Horny HP
Arch Gynecol Obstet; 2005 Sep; 272(3):223-8. PubMed ID: 16142475
[TBL] [Abstract][Full Text] [Related]
19. Mast cell subpopulations in the synovial tissue of patients with osteoarthritis: selective increase in numbers of tryptase-positive, chymase-negative mast cells.
Buckley MG; Gallagher PJ; Walls AF
J Pathol; 1998 Sep; 186(1):67-74. PubMed ID: 9875142
[TBL] [Abstract][Full Text] [Related]
20. Mast cell phenotype in benign and malignant tumors of the prostate.
Globa T; Saptefrţi L; Ceauşu RA; Gaje P; Cimpean AM; Raica M
Pol J Pathol; 2014 Jun; 65(2):147-53. PubMed ID: 25119176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
